Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors
Jack M. Qian(South Shore Hospital), Jonathan D. Schoenfeld(Brigham and Women's Hospital), Luke Pike(Memorial Sloan Kettering Cancer Center), Lauren Gunasti(Brigham and Women's Hospital), Jungwook Shin(National Cancer Center), Andrew Bang(Dana-Farber Cancer Institute), Clemens Grassberger(University of Washington), Elliot H. Akama‐Garren(Harvard University)
Cited by 11
Related Papers
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
|Cell|2022|376
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
|Clinical Cancer Research|2020|372